DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization

Summary

This is a prospective, randomized, double-blind, double-dummy, and controlled study of DLBS1033 in the management of acute non-ST elevation myocardial infarction (NSTEMI) without early coronary revascularization. It is hypothesized that the combination of DLBS1033 with aspirin and clopidogrel will result in greater reduction of infarct size in comparison with that of aspirin and clopidogrel alone.

Timeline

Start

2015-11

Primary completion

2017-11

Completion

2018-03

Drugs

Indications